CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Reconciliation of net income to cash provided by operating activities:
Net income	$ 163,525	$ 249,357
Add (deduct):
Depreciation and amortization	42,103	22,394
Adjustments for bad debt provisions	812	1,871
Net realized and unrealized losses (gains)	14,194	(17,816)
Amortization of net premium on debt securities investments	1,870	2,794
Payments for title losses less than provisions	10,950	39,761
Adjustments for insurance recoveries of title losses	220	0
Decrease (increase) in receivables – net	9,521	(20,771)
Increase in other assets – net	(4,343)	(3,725)
Decrease in accounts payable and other liabilities – net	(81,987)	(30,385)
Change in net deferred income taxes	25	7,024
Net income from equity method investments	(2,536)	(6,852)
Dividends received from equity method investments	3,135	5,496
Stock-based compensation expense	9,239	8,494
Other – net	312	(325)
Cash provided by operating activities	167,040	257,317
Investing activities:
Proceeds from sales of investments in securities	47,954	19,726
Proceeds from matured investments in debt securities	28,754	68,653
Purchases of investments in securities	(165,130)	(111,107)
Net (purchases) sales of short-term investments	(1,632)	2,734
Purchases of property and equipment, and real estate	(35,274)	(26,213)
Proceeds from sale of property and equipment and other assets	977	10,552
Cash paid for acquisition of businesses	(102,864)	(149,921)
Cash paid for acquisition of equity method investment	(69)	(16,080)
Other – net	1,941	988
Cash used by investing activities	(225,343)	(200,668)
Financing activities:
Proceeds from notes payable	38,012	331,755
Payments on notes payable	(75,505)	(158,031)
Distributions to noncontrolling interests	(14,863)	(11,683)
Repurchases of Common Stock	(3,168)	(2,145)
Proceeds from stock option and employee stock purchase plan exercises	5,799	2,715
Cash dividends paid	(32,464)	(26,558)
Payment of contingent consideration related to acquisitions	(15,997)	(9,489)
Purchase of remaining interest in consolidated subsidiaries	(72)	(5,616)
Other - net	115	(777)
Cash (used) provided by financing activities	(98,143)	120,171
Effects of changes in foreign currency exchange rates	(8,540)	(1,898)
Change in cash and cash equivalents	(164,986)	174,922
Cash and cash equivalents at beginning of period	485,919	432,683
Cash and cash equivalents at end of period	$ 320,933	$ 607,605